Quick Answer
Adagio Medical Holdings, Inc. reported Operating Income Loss of -$21.89 million for the year ending 2025.
- Adagio Medical Holdings, Inc. showed an increase of +21.7% in Operating Income Loss from 2023 to 2025.
- This data is from Adagio Medical Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2023 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: -$9.08 million | Q1 2024: -$8.82 million | Q2 2024: -$6.66 million | Q3 2024: -$6.21 million | Q3 2024: -$4.43 million | Q1 2025: -$7.40 million | Q2 2025: -$4.72 million | Q3 2025: -$5.72 million.
- Historical annual values: Fiscal year 2025: -$21.89 million | Fiscal year 2023: -$27.94 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: